Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

STRATA Skin Sciences (SSKN) Long-Term Debt Repayments (2016 - 2021)

STRATA Skin Sciences' Long-Term Debt Repayments history spans 7 years, with the latest figure at $7.3 million for Q3 2021.

On a quarterly basis, Long-Term Debt Repayments changed N/A to $7.3 million in Q3 2021 year-over-year; TTM through Dec 2022 was $14.9 million, a N/A change, with the full-year FY2021 number at $500000.0, changed N/A from a year prior.
Long-Term Debt Repayments hit $7.3 million in Q3 2021 for STRATA Skin Sciences, down from $7.6 million in the prior quarter.
Over the last five years, Long-Term Debt Repayments for SSKN hit a ceiling of $7.6 million in Q4 2019 and a floor of $103000.0 in Q3 2017.
Historically, Long-Term Debt Repayments has averaged $2.4 million across 4 years, with a median of $663000.0 in 2017.
The widest YoY moves for Long-Term Debt Repayments: up 2515.53% in 2018, down 0.0% in 2018.
Tracing SSKN's Long-Term Debt Repayments over 4 years: stood at $1.1 million in 2017, then soared by 139.47% to $2.7 million in 2018, then surged by 181.03% to $7.6 million in 2019, then decreased by 3.58% to $7.3 million in 2021.
Business Quant data shows Long-Term Debt Repayments for SSKN at $7.3 million in Q3 2021, $7.6 million in Q4 2019, and $2.7 million in Q3 2018.